0001305253-16-000005.txt : 20160429 0001305253-16-000005.hdr.sgml : 20160429 20160428180407 ACCESSION NUMBER: 0001305253-16-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160429 DATE AS OF CHANGE: 20160428 EFFECTIVENESS DATE: 20160429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330971591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-262254 FILM NUMBER: 161601552 BUSINESS ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-272-6138 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVE STREET 2: SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 D 1 primary_doc.xml X0707 D LIVE 0001305253 Eiger BioPharmaceuticals, Inc. 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA CALIFORNIA 94306 650-272-6138 DELAWARE Celladon Corp Corporation true David A. Cory 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer Director Edgar G. Engleman 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Jeffrey S. Glenn 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Nina Kjellson 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Thomas J. Dietz 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director Charles Bramlage 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Director James H. Welch 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer Joanne Quan 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer James P. Shaffer 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer Eduardo Bruno Martins 350 Cambridge Ave., Suite 350 Palo Alto CA CALIFORNIA 94306 Executive Officer Biotechnology No Revenues 06b false 2016-04-20 false true false 0 3000000 2999982 18 false 1 0 0 0 false Eiger BioPharmaceuticals, Inc. /s/ David Cory David Cory President and CEO 2016-04-28